CD4 and neoplasm: In terms of mechanisms, the Th1 immune responses, including those mediated by cytotoxic CD8+ and CD4+ Th1 T cells, along with their characteristic Th1-associated cytokines, function as the major anti-tumor immune pathways restricting disease progression.